Jefferies is cutting its price target on Orasure (OSUR -13.3%) on the back of yesterdays weaker...

|By:, SA News Editor

Jefferies is cutting its price target on Orasure (OSUR -13.3%) on the back of yesterdays weaker than anticipated FY13 guidance. The firm cites lower base business expectations, but reiterates that the guidance shortfall is not related to tempered expectations surrounding new product launches. It says that FY13 revenue forecasts for OSUR's U.S. HCV & OTC HIV markets are unchanged, and reiterates a Buy on the shares. Read more on OSUR's earnings call here: Earnings Call Transcript.